Dr Reddy's Laboratories Total Assets 2006-2020 | RDY

Dr Reddy's Laboratories total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Dr Reddy's Laboratories total assets for the quarter ending June 30, 2020 were $3.326B, a 0.94% increase year-over-year.
  • Dr Reddy's Laboratories total assets for 2020 were $3.081B, a 5.46% decline from 2019.
  • Dr Reddy's Laboratories total assets for 2019 were $3.259B, a 5.95% decline from 2018.
  • Dr Reddy's Laboratories total assets for 2018 were $3.465B, a 2.21% increase from 2017.
Dr Reddy's Laboratories Annual Total Assets
(Millions of US $)
2020 $3,081
2019 $3,259
2018 $3,465
2017 $3,390
2016 $3,134
2015 $3,126
2014 $2,837
2013 $2,611
2012 $2,348
2011 $2,133
2010 $1,787
2009 $1,646
2008 $2,135
2007 $1,993
2006 $1,546
2005 $671
Dr Reddy's Laboratories Quarterly Total Assets
(Millions of US $)
2020-06-30 $3,326
2020-03-31 $3,081
2019-12-31 $3,054
2019-09-30 $3,311
2019-06-30 $3,295
2019-03-31 $3,259
2018-12-31 $3,258
2018-09-30 $3,229
2018-06-30 $3,372
2018-03-31 $3,465
2017-12-31 $3,540
2017-09-30 $3,400
2017-06-30 $3,380
2017-03-31 $3,390
2016-12-31 $3,345
2016-09-30 $3,311
2016-06-30 $2,896
2016-03-31 $3,134
2015-12-31 $3,141
2015-09-30 $3,091
2015-06-30 $3,164
2015-03-31 $3,126
2014-12-31 $2,925
2014-09-30 $2,848
2014-06-30 $2,890
2014-03-31 $2,837
2013-12-31 $2,715
2013-09-30 $2,575
2013-06-30 $2,536
2013-03-31 $2,611
2012-12-31 $2,531
2012-09-30 $2,467
2012-06-30 $2,279
2012-03-31 $2,348
2011-12-31 $2,310
2011-09-30 $2,198
2011-06-30 $2,197
2011-03-31 $2,133
2010-12-31 $1,874
2010-09-30 $1,792
2010-06-30 $1,765
2010-03-31 $1,787
2009-12-31 $1,565
2009-09-30 $1,711
2009-06-30 $1,761
2009-03-31 $1,646
2008-12-31 $1,983
2008-09-30 $2,057
2008-06-30 $2,120
2008-03-31 $2,135
2007-12-31 $2,003
2007-09-30 $2,038
2007-06-30 $1,927
2007-03-31 $1,993
2006-12-31 $1,969
2006-09-30 $1,808
2006-06-30 $1,689
2006-03-31 $1,546
2005-12-31 $730
2005-09-30 $720
2005-06-30 $711
2005-03-31 $671
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.362B $2.316B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $9.437B 3.57
Mylan (MYL) United States $7.429B 3.14
Bausch Health Cos (BHC) Canada $5.587B 4.25
BridgeBio Pharma (BBIO) United States $4.729B 0.00
ASPEN PHARMACR (APNHY) South Africa $3.081B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.076B 9.24
Amphastar Pharmaceuticals (AMPH) United States $0.863B 36.36
Personalis (PSNL) United States $0.709B 0.00
Assembly Biosciences (ASMB) United States $0.529B 0.00
Homology Medicines (FIXX) United States $0.486B 0.00
Voyager Therapeutics (VYGR) United States $0.432B 0.00
CymaBay Therapeutics (CBAY) United States $0.429B 0.00
Sol-Gel Technologies (SLGL) Israel $0.146B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.134B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.095B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.091B 0.13
China Pharma Holdings (CPHI) China $0.016B 0.00
Teligent (TLGT) United States $0.004B 0.00